Added to YB: 2026-08-04
Pitch date: 2026-08-01
NRXS [neutral]
NeurAxis, Inc.
+4.11%
current return
Author Info
Microcap Opportunities is a community dedicated to finding the best opportunities in the MicroCap space for US and Canadian listings primarily. Sign up for the newsletter.
Company Info
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
Market Cap
$77.4M
Pitch Price
$6.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
-9.96
P/E
-7.71
EV/Sales
16.51
Sector
Health Care Equipment and Supplies
Category
growth
The Multibaggers - NeurAxis (NRXS)
NRXS (holding update): +96.5% since 8/17/24 add @$3.18. July 23 S-3 resale prospectus (1.9M shares from insiders/directors/RSU holders) confused investors — it's a legal prereq to sell, not a sale. Fundamentals unchanged. Key catalyst: additional insurance payors (when, not if) + Aug 11 ER showing IB-Stim device adoption.
Read full article (1 min)